Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emma Weizenbaum, Ph.D.

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Learning Curve120232080.830 Why?
Video Games120211840.660 Why?
Ketoprofen1201380.480 Why?
Tromethamine12013310.480 Why?
Memory1202321740.460 Why?
Tryptamines12013880.460 Why?
Carbazoles120132260.410 Why?
Data Collection1202033410.380 Why?
Parkinson Disease2202127750.360 Why?
Headache4201612260.300 Why?
Analgesics1201310400.280 Why?
Cognition2202167700.280 Why?
Migraine Disorders2201816200.260 Why?
Feasibility Studies2202350780.210 Why?
Activities of Daily Living2202024180.180 Why?
Computers, Handheld120202080.160 Why?
Amitriptyline120161100.140 Why?
Pituitary Diseases120161410.130 Why?
Reproducibility of Results22023199050.120 Why?
Analgesics, Non-Narcotic120163650.110 Why?
Health Services120187580.110 Why?
Self Concept1201810250.110 Why?
Social Stigma120187010.100 Why?
Motivation1202119710.100 Why?
Functional Laterality1201822900.100 Why?
Boston1202393130.090 Why?
Anxiety Disorders1202126900.090 Why?
Neuropsychological Tests1202169930.080 Why?
Choice Behavior120138030.080 Why?
Physician's Role120139430.070 Why?
Neurology120147630.070 Why?
Fellowships and Scholarships1201410760.070 Why?
Patient Participation1201314570.060 Why?
Alzheimer Disease1202380370.050 Why?
Societies, Medical1201337430.050 Why?
Humans1220237443430.050 Why?
Stress Disorders, Post-Traumatic1201842660.050 Why?
Aged520231632800.040 Why?
Depression1201877660.040 Why?
Pain Clinics12016490.040 Why?
Memory Disorders1202311840.040 Why?
Censuses120142000.030 Why?
Random Allocation1201824290.030 Why?
Amyloid beta-Peptides1202335870.020 Why?
Self Report1202135580.020 Why?
Prevalence22018152260.020 Why?
Treatment Outcome12016631140.020 Why?
Demography1201416560.020 Why?
Male620183501180.020 Why?
Female620183801940.020 Why?
Positron-Emission Tomography1202362340.020 Why?
Disease Progression12023132840.020 Why?
Anxiety1202142970.020 Why?
Program Evaluation1201424880.020 Why?
Sex Factors12018103970.020 Why?
Dose-Response Relationship, Drug12016109430.010 Why?
Adult420212140550.010 Why?
Middle Aged420182133830.010 Why?
Age Factors12018183700.010 Why?
Curriculum1201436050.010 Why?
Young Adult22018564300.010 Why?
Longitudinal Studies12016139890.010 Why?
Adolescent22018857810.010 Why?
Practice Guidelines as Topic1201372790.010 Why?
United States22014698720.010 Why?
Physicians1201345670.010 Why?
Cohort Studies12016405610.010 Why?
Aged, 80 and over12018577760.010 Why?
Retrospective Studies12014774490.000 Why?
Weizenbaum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.